The impact of infection is significant in Cheshire & Merseyside.
Low levels of immunisation and health inequalities make members of the local population more vulnerable.
We also know that people with health conditions, such as asthma, cystic fibrosis, heart, liver or kidney problems, in addition to those receiving chemotherapy, are at increased risk of developing infection.
With rates of cancer and cardiovascular disease higher than the UK average in the region there is an increased threat from infection for patients in these treatment areas.
Infection can affect any area of the body. It can spread through the blood, causing inflammation and have damaging consequences. Anyone with an infection may also develop sepsis, which may need treatment with antibiotics depending on the cause.
Between 2013/14 and 2017/18, more than a million bed days in Liverpool resulted from serious infection.
Antimicrobial resistance (AMR) poses a significant threat to the delivery of healthcare. It is essential to ensure that principles of good antimicrobial stewardship, plus appropriate use of antibiotics is built into all activities, communication, training and actions relating to the treatment of sepsis.
Antimicrobials are fundamental components of our health system and AMR strikes the poor hardest so is another important issue for our region.
We will continue to use Liverpool’s experience to inform the definition of infection challenges in the Liverpool City Region, as it applies to our patients, population, health care workers and the healthcare system.